Alimera Sciences, Inc.

NASDAQ:ALIM

5.54 (USD) • At close September 13, 2024
Bedrijfsnaam Alimera Sciences, Inc.
Symbool ALIM
Munteenheid USD
Prijs 5.54
Beurswaarde 301,288,468
Dividendpercentage 0%
52-weken bereik 2.606 - 5.65
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Richard S. Eiswirth Jr.
Website https://alimerasciences.com

An error occurred while fetching data.

Over Alimera Sciences, Inc.

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to

Vergelijkbare Aandelen

STRATA Skin Sciences, Inc. logo

STRATA Skin Sciences, Inc.

SSKN

3.01 USD

Eargo, Inc. logo

Eargo, Inc.

EAR

2.57 USD

Greenbrook TMS Inc. logo

Greenbrook TMS Inc.

GBNH

0.121 USD

Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.

ELDN

2.65 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)